StockData
Ginkgo Bioworks Holdings, Inc. logo

Ginkgo Bioworks Holdings, Inc. (DNA) stock

DNANYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3020% below fair value
$7.46−0.74 (-9.02%)

Close on Nov 20, 2026Market cap $502.36MP/E –Yield –

Ginkgo Bioworks gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$18.44M–
Q1 FY2026Mar 31, 2026$16.38M–
Q2 FY2025Jun 30, 2025$33.75M–
Q1 FY2025Mar 31, 2025$34.14M–

More Ginkgo Bioworks figures

See a number that looks wrong?